ADAPTIVE BIOTECHNOLOGIES CORPORATION Other Noncash Income (Expense)
ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) reported Other Noncash Income (Expense) of $106.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2026-08-04
- ADAPTIVE BIOTECHNOLOGIES CORPORATION other noncash income (expense) for the quarter ending 2026-06-30 was $120.00K, a 263.64% increase year-over-year.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION other noncash income (expense) for the quarter ending 2026-03-31 was -$14.00K.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION other noncash income (expense) for the quarter ending 2025-12-31 was -$101.00K, a 941.67% decline year-over-year.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION other noncash income (expense) for the quarter ending 2025-09-30 was -$434.00K, a 4440.00% decline year-over-year.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION other noncash income (expense) for fiscal 2025 was -$578.00K.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION other noncash income (expense) for fiscal 2024 was -$141.00K.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION other noncash income (expense) for fiscal 2023 was -$172.00K, a 1005.26% decline from fiscal 2022.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION other noncash income (expense) for fiscal 2022 was $19.00K, a 75.64% decline from fiscal 2021.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 6 month as first filed | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 9 month as first filed | Other Noncash Income (Expense) 12 month | Other Noncash Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $120.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $106.00K 10-Q · filed 2026-08-04 | $5.00K derived: sum of 3 quarters · filed 2026-08-04 | -$429.00K derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2026-03-31 | -$14.00K 10-Q · filed 2026-05-05 | -$115.00K derived: sum of 2 quarters · filed 2026-05-05 | -$549.00K derived: sum of 3 quarters · filed 2026-05-05 | -$516.00K derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-12-31 | -$101.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$535.00K derived: sum of 2 quarters · filed 2026-02-26 | -$502.00K derived: sum of 3 quarters · filed 2026-08-04 | -$578.00K 10-K · filed 2026-02-26 | |||
| 2025-09-30 | -$434.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$401.00K derived: sum of 2 quarters · filed 2026-08-04 | -$477.00K 10-Q · filed 2025-11-05 | -$465.00K derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-06-30 | $33.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$43.00K 10-Q · filed 2026-08-04 | -$31.00K derived: sum of 3 quarters · filed 2026-08-04 | -$21.00K derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-03-31 | -$76.00K 10-Q · filed 2026-05-05 | -$64.00K derived: sum of 2 quarters · filed 2026-05-05 | -$54.00K derived: sum of 3 quarters · filed 2026-05-05 | -$103.00K derived: sum of 4 quarters · filed 2026-05-05 | |||
| 2024-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $22.00K derived: sum of 2 quarters · filed 2026-02-26 | -$27.00K derived: sum of 3 quarters · filed 2026-02-26 | -$141.00K 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$39.00K derived: sum of 2 quarters · filed 2025-11-05 | -$153.00K 10-Q · filed 2025-11-05 | -$160.00K derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-06-30 | -$49.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$163.00K 10-Q · filed 2025-08-05 | -$170.00K derived: sum of 3 quarters · filed 2026-02-26 | -$270.00K derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-03-31 | -$114.00K 10-Q · filed 2025-05-01 | -$121.00K derived: sum of 2 quarters · filed 2026-02-26 | -$221.00K derived: sum of 3 quarters · filed 2026-02-26 | -$281.00K derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2023-12-31 | -$7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$107.00K derived: sum of 2 quarters · filed 2026-02-26 | -$167.00K derived: sum of 3 quarters · filed 2026-02-26 | -$172.00K 10-K · filed 2026-02-26 | |||
| 2023-09-30 | -$100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$160.00K derived: sum of 2 quarters · filed 2024-11-07 | -$165.00K 10-Q · filed 2024-11-07 | -$166.00K derived: sum of 4 quarters · filed 2025-03-03 | |||
| 2023-06-30 | -$60.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$65.00K 10-Q · filed 2024-08-01 | -$66.00K derived: sum of 3 quarters · filed 2025-03-03 | -$65.00K derived: sum of 4 quarters · filed 2025-03-03 | |||
| 2023-03-31 | -$5.00K 10-Q · filed 2024-05-07 | -$6.00K derived: sum of 2 quarters · filed 2025-03-03 | -$5.00K derived: sum of 3 quarters · filed 2025-03-03 | -$6.00K derived: sum of 4 quarters · filed 2025-03-03 | |||
| 2022-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $0.00 derived: sum of 2 quarters · filed 2025-03-03 | -$1.00K derived: sum of 3 quarters · filed 2025-03-03 | $19.00K 10-K · filed 2025-03-03 | |||
| 2022-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $20.00K 10-Q · filed 2023-11-09 | $89.00K derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $19.00K 10-Q · filed 2023-08-02 | $88.00K derived: sum of 3 quarters · filed 2024-02-29 | $90.00K derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-03-31 | $20.00K 10-Q · filed 2023-05-03 | $89.00K derived: sum of 2 quarters · filed 2024-02-29 | $91.00K derived: sum of 3 quarters · filed 2024-02-29 | $89.00K derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2021-12-31 | $69.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $71.00K derived: sum of 2 quarters · filed 2024-02-29 | $69.00K derived: sum of 3 quarters · filed 2024-02-29 | $78.00K 10-K · filed 2024-02-29 | |||
| 2021-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $0.00 derived: sum of 2 quarters · filed 2022-11-03 | $9.00K 10-Q · filed 2022-11-03 | $0.00 derived: sum of 4 quarters · filed 2023-02-14 | |||
| 2021-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $7.00K 10-Q · filed 2022-08-03 | -$2.00K derived: sum of 3 quarters · filed 2023-02-14 | -$15.00K derived: sum of 4 quarters · filed 2023-02-14 | |||
| 2021-03-31 | $9.00K 10-Q · filed 2022-05-04 | $0.00 derived: sum of 2 quarters · filed 2023-02-14 | -$13.00K derived: sum of 3 quarters · filed 2023-02-14 | $52.00K derived: sum of 4 quarters · filed 2023-02-14 | |||
| 2020-12-31 | -$9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | -$22.00K derived: sum of 2 quarters · filed 2023-02-14 | $43.00K derived: sum of 3 quarters · filed 2023-02-14 | -$71.00K 10-K · filed 2023-02-14 | |||
| 2020-09-30 | -$13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $52.00K derived: sum of 2 quarters · filed 2021-11-03 | -$62.00K 10-Q · filed 2021-11-03 | -$501.00K derived: sum of 4 quarters · filed 2022-02-15 | |||
| 2020-06-30 | $65.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$49.00K 10-Q · filed 2021-08-04 | -$488.00K derived: sum of 3 quarters · filed 2022-02-15 | -$486.00K derived: sum of 4 quarters · filed 2022-02-15 | |||
| 2020-03-31 | -$114.00K 10-Q · filed 2021-05-05 | -$553.00K derived: sum of 2 quarters · filed 2022-02-15 | -$551.00K derived: sum of 3 quarters · filed 2022-02-15 | ||||
| 2019-12-31 | -$439.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | -$437.00K derived: sum of 2 quarters · filed 2022-02-15 | -$359.00K 10-K · filed 2022-02-15 | -$43.00K 10-K · filed 2020-02-26 | |||
| 2019-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $80.00K 10-Q · filed 2020-11-10 | $8.00K 10-Q · filed 2019-11-12 | ||||
| 2019-06-30 | $78.00K 10-Q · filed 2020-08-10 | -$1.00K 10-Q · filed 2019-08-13 | |||||
| 2018-12-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $21.00K derived: sum of 2 quarters · filed 2021-02-24 | $18.00K 10-K · filed 2021-02-24 | -$5.00K 10-K · filed 2020-02-26 | |||
| 2018-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$4.00K 10-Q · filed 2019-11-12 | |||||
| 2018-06-30 | -$3.00K 10-Q · filed 2019-08-13 | ||||||
| 2017-12-31 | -$6.00K 10-K · filed 2020-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |